Primary aldosteronism: Evidence against a second epidemic

Journal of Hypertension

Volumn 30, Issue 10, 2012, Pages 1899-1902

  Kaplan, Norman M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

adrenalectomy; aldosterone to renin ratio; mineralocorticoid receptor antagonists; primary aldosteronism

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; MINERALOCORTICOID ANTAGONIST; RENIN;

ACCURACY; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; HUMAN; HYPERTENSION; HYPOKALEMIA; MEDICAL DOCUMENTATION; PATIENT REFERRAL; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SCREENING TEST;

EID: 84866545065     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283559a03     Document Type: Review

References (30)

1. Conn JW. Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1955; 45:3-6.
2. Conn JW, Cohen EL, Rovner DR, Nesbit RM. Normokalemic primary aldosteronism. A detectable cause of curable 'essential' hypertension. JAMA 1965; 193:200-206.
3. Kaplan NM, Victor RG. Primary aldosteronism. Kaplan's clinical hypertension, 10th ed. Philadelphia; 2010. pp. 330-357.
4. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21:315-318.
5. Kaplan NM. Primary aldosteronism: a contrarian view. Rev Endocr Metab Disord 2011; 12:49-52.
6. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93:3266-3281.
7. Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient's cohorts and in population-based studies: a review of the current literature. Horm Metab Res 2012; 44:157-162.
8. Ito Y, Takeda R, Karashima S, Yamamoto Y, Yoneda T, Takeda Y. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res 2011; 34:98-102.
9. Westerdahl C, Bergenfelz A, Isaksson A, Nerbrand C, Valdemarsson S. Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. Scand J Prim Health Care 2011; 29:57-62.
10. Choi M, Scholl U, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, et al. K channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011; 331:768-772.
11. Azizan EAB, Murthy M, Stowasser M, Gordon R, Kowalski B, Xu S, et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in two large unselected collections of adrenal aidosteronomas. Hypertension 2012; 59:587-591.
12. Boulkroun S, Beuschlein F, Rossi G-P, Golib-Dzib J-F, Fischer E, Amar L, et al. Prevalence, clinical and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 2012; 59:592-598.
13. Carvajal C, Campino C, Martinez-Aguayo A, Tichauer JE, Bancalari R, Valdivia C, et al. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern. Hypertension 2012; 59:85-91.
14. Fischer E, Beuschlein F, Bidlingmaier M, Reincke M. Commentary on the Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldoster-onism. Rev Endocr Metab Disord 2011; 12:43-48.
15. Rossi GP. Diagnosis and treatment of primary aldosteronism. Rev Endocr Metab Disord 2011; 12:27-36.
16. Tomaschitz A, Pilz S. Aldosterone to renin ratio: a reliable screening tool for primary aldosteronism? Horm Metab Res 2010; 42:382-391.
17. Stowasser M. Update in primary aldosteronism. J Clin Endocrinol Metab 2009; 94:3623-3630.
18. Ahmed AH, Calvird M, Gordon RD, Taylor PJ, Ward G, Pimenta E, et al. Effects of two selective serotonin reuptake inhibitor antidepressants, sertaline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients. J Clin Endocrinol Metab 2011; 96:1039-1045.
19. Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J Clin Endocrinol Metab 2011; 96:1797-1804.
20. Monticone S, Viola A, Tizzani V, Crudo V, Burrello M, Galmozzi F, et al. Primary aldosteronism: who should be screened? Horm Metab Res 2012; 44:163-169.
21. Funder J. Envoi. Rev Endoc Metab Disord 2011; 12:53-54.
22. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45:1243-1248.
23. van der Linden P, Steichen O, Zinzindohoue F, Plouin P-F. Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study. J Hypertens 2012; 30:761-769.
24. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007; 66:607-618.
25. Nwariaku FE, Miller BS, Auchus R, Holt S, Watumull L, Dolmatch B, et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 2006; 141:497-503.
26. Auchus RJ, Wians FH Jr, Anderson ME, Dolmatch BL, Trimmer CK, Josephs SC, et al. What we still do not know about adrenal vein sampling for primary aldosteronism. Horm Metab Res 2010; 42:411-415.
27. Monticone S, Satoh F, Giacchetti G, Viola A, Morimoto R, Kudo S, et al. Effect of adrenocorticotropic hormone stimulation during adrenal venous sampling in primary aldosteronism. Hypertension 2012; 59:840-846.
28. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008; 168:80-85.
29. Ahmed AH, Gordon RD, Sukor N, Pimenta E, Stowasser M. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. J Clin Endocrinol Metab 2011; 96:2904-2911.
30. Funder JW. Primary aldosteronism: are we missing the wood for the trees? Horm Metab Res 2012; 44:251-255.